Elevation Oncology Inc (ELEV) last year’s performance of -91.21% is a clear signal for an entertaining trading season.
On Thursday, Elevation Oncology Inc (NASDAQ: ELEV) was 16.72% up from the session before settling in for the closing price of $0.33. A 52-week range